COL1A2 and cancer: We have observed the elevated mRNA level of the COL1A2 in COAD in the earlier section, and then we evaluated the COL1A2 expression in COAD based on various clinicopathological characteristics like age, gender, weight, histological subtypes, cancer stage, and nodal metastasis status (Figure 3A–3F).